Mitos Therapeutics Inc. is a specialized biopharmaceutical venture company pioneering the development of the world’s first therapeutic for sarcopenia, leveraging its proprietary foundational technologies. Additionally, the company is engaged in the discovery of bioactive compounds using its therapeutic development platform, which it applies to the development of health-functional ingredients and products.